A Cost-Effectiveness Analysis of an Adjuvanted Subunit Vaccine for the Prevention of Herpes Zoster and Post-Herpetic Neuralgia

BACKGROUND: Herpes zoster (HZ) develops in up to 50% of unvaccinated individuals who live to 85 years of age, accounting for more than 1 million cases of HZ annually in the United States. A live attenuated vaccine (LAV) for HZ is U.S. FDA approved for persons 50 years or older, though CDC Advisory C...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Open Forum Infect Dis
Main Authors: Carpenter, Christopher, Aljassem, Annas, Stassinopoulos, Jerry, Pisacreta, Giovanni, Hutton, David
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2017
Fag:
Abstracts
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5631538/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.1043
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker